|
Biomerieux SA - Company Profile Snapshot
| Company Profile: |
Biomerieux SA |
| Ticker: |
BIM |
| Exchanges: |
PAR |
| 2008 Sales: |
1,110,500,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
FRANCE |
| Employees: |
6140 |
Business Description
Biomerieux SA. The Group's principal activity is to provide clinical diagnosis. The Group offers 'in vitro' diagnosis which serves as the basis for medical diagnosis, patient treatment and therapy monitoring. The Group contributes to the field of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory infection and pathologies such as cancer and cardiovascular diseases. The Group performs clinical diagnosis through three technologies, bacteriology, immunoassays and molecular biology. The industrial applications include the analysis of the industrial sample like food, pharmaceutical and cosmetic products. The environment sample of water, air and surface determines the microbiological quality. The Group operates in Europe, North America, Asia-Pacific and Latin America.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
